Mentor Capital Adds Three Cannabis Investments in Two Months

SAN DIEGO--(BUSINESS WIRE)--Mentor Capital, Inc. (OTCQX: MNTR) announced that its investment in G
FarmaLabs Limited has increased to $2,700,000 following yesterday’s
seventh investment tranche delivered to G Farma of $250,000 from Mentor
for additional leased equipment and working capital. In addition to
receiving consulting fees, repayment, interest, and lease payments,
Mentor has captured a $1 option for a 3.75% equity interest in the G
Farma Family of Businesses. Nicole Gonzalez, Founder of G FarmaBrands,
comments, “With financial backing from Mentor Capital, G FarmaLabs has
hit its benchmarks on the way to building cannabis efficient facilities
and production lines.” Ata Gonzalez, Co-Founder of G FarmaLabs
concludes, “Chet provides both money and a wealth of knowledge. We feel
blessed to have this strategic relationship.”

“Mentor Capital focuses new investment from shareholders and other
investors on larger cannabis companies, like G Farma, that have the
potential to go public and who may be incubated by Mentor along that
path,” explained Mentor Capital, Inc. CEO, Chet Billingsley. “We look to
act as a holding company of operating entities, not an investment
company, and have no plans to buy cannabis shares from the public market
at normal market prices. However, on 24-hour notice and hence at a
significant discount, Mentor will buy public shares from
marijuana-related consultants, institutions, or accredited investors
that Mentor has known for years.”

The Company reports that in the last two months, Mentor has increased
its holding in SolisTek to 300,000 shares by the purchase of an
additional 90,000 common shares. Mentor recently has purchased 400,000
shares of GB Sciences, Inc. plus an extra 400,000 of their warrants.
Mentor also holds from earlier buying activity approximately a combined
$240,000 in shares of GW Pharmaceuticals, Plc. and Kush Bottles, Inc.

About Mentor Capital:

The Company seeks to come alongside and assist private medical marijuana
and cannabis companies and their founders in meeting their liquidity and
financial objectives, to add protection for investors and to help
incubate larger private cannabis companies. Additional important
information for investors is presented at:

This press release is neither an offer to sell nor a solicitation of
offers to purchase securities.

Forward-Looking Statements:This press release contains
forward-looking statements within the meaning of the federal securities
laws, including statements concerning financial projections, financing
activities, corporate combinations, product development activities and
sales and licensing activities.Such forward-looking statements
are not guarantees of future results or performance, are sometimes
identified by words of condition such as “should,” “could,” “expects,”
“may,” “intends,” “seeks,” “looks,” “moves,” or “plans” and are subject
to a number of risks and uncertainties, known and unknown, that could
cause actual results to differ materially from those intended or
anticipated.Such risks include, without limitation:
nonperformance of investments, partner and portfolio difficulties,
potential delays in marketing and sales, problems securing the necessary
financing to continue operations, problems involving continued
illegality ofcannabis products, potential of competitive
products, services, and technologies, difficulties experienced in
product development, in recruiting knowledgeable personnel and in
protecting intellectual property.Further information concerning
these, and other risks is included in the Company’s Form 10-K filing
which, along with other very important information about the Company,
can be found here: